| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to: medicine, and aims at treating cancer carrying EGFR mutations. What is declared is using BIBW 2992 (1) for preparing a pharmaceutical composition for treating patients suffering gefitinib and/or erlotinib resistant cancer.EFFECT: using the declared invention is effective for treating the patients suffering cancer diseases with EGFR mutations in the tumour.1 tbl, 10 ex |
